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Von Willebrand disease (VWD) is characterised by a qualitative or quantitative defect in von 
Willebrand factor (VWF) resulting in a bleeding tendency such as mucocutaneous bleeding. It 
is the most common inherited bleeding disorder [1]. VWF has a pivotal role in both primary 
and secondary haemostasis as it captures platelets at sites of endothelial damage and has a 
carrier function for factor VIII (FVIII). Recently, a role for VWF in regulating blood vessel 
formation has been demonstrated [2], with a loss of endothelial VWF resulting in 
dysregulated angiogenesis.  
Angiodysplastic lesions in VWD are mostly reported in the gastrointestinal tract with 
frequencies of 2% in type 2 VWD, 4.5% in type 3 VWD, and 11.5% in acquired VWD [3]. 
Despite this well-recognised gastrointestinal angiodysplasia, vascular malformation in other 
tissues are rarely reported, and it is unknown if the reason is poor reporting or that the lesions 
do not occur outside the gastrointestinal tract. Here we present three cases of VWD and 
abnormal angiogenesis outside the gastro-intestinal tract. 
The first case is a 32-year-old man diagnosed with type 2M VWD due to a c.4120C>T 
mutation and leading to lifelong easy bruising and epistaxis. His baseline VWF activity is 8% 
(normal range 50-172%), VWF antigen 21% (46-146%), FVIII 54% (52-184%) and he has a 
qualitatively normal multimer pattern. On physical examination he was found to have a large 
venous malformation around his left ankle and a varicose vein on his left calf, both present 
since birth.  
His grandfather was also diagnosed with type 2M VWD with a VWF activity of 1%, VWF 
antigen of 24%, FVIII 37%, and similar to his grandson a normal multimer pattern. At the age 
of 70, he developed a prominent cluster of angiomas on his glans penis with a few on the 
scrotum, histologically confirmed to be angiokeratomas. Later in life they became more 
prominent and troublesome, requiring laser therapy.  
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The third case is a man with type 2A VWD (familial mutation c.4493A>T) who suffered from 
severe bleeding due to intestinal angiodysplasia. He received over 300 units of blood before 
responding to high dose atorvastatin in 2008 [4]. He died two years later due to a myocardial 
infarction. On autopsy he had multiple angiomatoid littoral cell hamartomas in the spleen, 
alongside his known gastrointestinal angiodysplasia. 
Recurrent gastrointestinal bleeding is a serious complication in VWD, and an increased 
prevalence of gastrointestinal angiodysplasia in VWD is assumed. This might be an 
overestimation reflecting the increased likelihood of becoming clinically evident due to the 
bleeding tendency. Nonetheless, recent preclinical data suggest that a lack of VWF results in 
dysregulated angiogenesis [2], and there is no reason why this should be restricted to the gut.  
Reports of non-gastrointestinal angiodysplasia associated with VWD are limited. Clinically, 
when refractory epistaxis is observed, nasal arteriovenous malformations are considered but 
these cases are hardly reported. In f a woman with type 2B VWD and significant 
angiodysplasia of the gastrointestinal tract, significant epistaxis due to a large number of 
telangiectases in the nasal cavity is described [5]. The second report is of a young woman 
with VWD and angiodysplasia in the lung, but this could have been due to coinheritance of 
VWD and hereditary haemorrhagic telangiectasia (HHT) as both her father and grandfather 
also suffered from pulmonary angiodysplasia in the absence of a bleeding disorder [6]. The 
VWF gene is located on chromosome 12, as is the ACVRL1 gene coding for activin receptor-
like kinase 1 with mutations causing HHT type 2.A third male patient had symptoms of 
recurrent haematuria and haematospermia with prostatic telangiectasia and VWD [7]. 
Recently a case of type 1 VWD and haematuria with haematospermia was reported without 
evidence of prostatic or cystic angiodysplasia, possibly because it can be difficult to document 
angiodysplastic lesions [8].  
4 
 
In two of the three cases we describe the multimer pattern is normal, whereas previously it 
was thought that angiodysplasia was associated with VWD subtypes lacking high-molecular 
weight multimers (HMWM). In an older, large international survey conducted in 4503 VWD 
patients, angiodysplasia was reported only in patients with type 2 and type 3 VWD [3].  More 
recently, the VWD Prophylaxis Network reported angiodysplasia in nine patients with type 1 
VWD [9], in addition to three other cases reported by a group from Italy [10]. Based on the 
antiangiogenic properties ascribed to VWF, it is possible that the level of functional VWF is 
also of importance as well as the loss of HMWM specifically.  
As both VWD and vascular malformations are relatively common, case-control studies are 
needed to elucidate whether VWF also has a role in the development of extra-intestinal 
vascular malformations. In future cases of VWD with extra-intestinal angiodysplasias, it 
would be worthwhile genotyping for endoglin and ACVRL1 mutations for possible 
coinheritance of HHT. Likewise, it would be interesting to conduct a study examining the 
prevalence of nasal angiodysplasias in VWD patients with refractory epistaxis. These efforts 
could elucidate whether what we are reporting is a coincidence or a related pathogenic 
process 
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